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ABSTRACT. This article is a qualitative investigation of the subjective experience of re-
covery from the perspective of persons living with schizophrenia-related disorders. An
NIMH-sponsored ethnographic study of community outpatient clinics was completed for
90 persons taking second-generation antipsychotic medications. Research diagnostic cri-
teria and clinical ratings were obtained in tandem with an anthropologically developed
Subjective Experience of Medication Interview (SEMI) that elicits narrative data on ev-
eryday life and activities, medication and treatment, management of symptoms, expecta-
tions concerning recovery, and stigma. Ethnographic observations from diverse settings
(clinics, public transportation, restaurants, homes) were also obtained. The primary find-
ings are that recovery was experienced in relation to low levels of symptoms, the need
to take medications to avoid hospitalization or psychotic episodes, and personal agency
to struggle against the effects of illness. The majority of participants articulated their
sense of illness recovery and expectation that their lives would improve. Improvement
and recovery is an incremental, yet definitively discernable subjective process. Several
problems were identified as part of this process surrounding cultural conflicts that gen-
erate the experience of ambivalence analyzed here as the “paradox of recovery without
cure,” irreconcilable “catch-22” dilemmas involving sacrifice (e.g., one must be “fat”
or be “crazy”), and substantial stigma despite improvement in illness and everyday life
experience.
KEY WORDS: culture, recovery, schizophrenia, psychopharmacology, atypical antipsy-
chotics
In the great majority of cases the periods of improvement do not last longer than
three years. . . . Among all the cases ultimately leading to dementia [praecox] the
proportion of periods of improvement resembling recovery only amounted to about
2.6 percent . . . after the initial improvement [there is] a gradual deterioration of
the psychic state.
—E. Kraepelin, 1919
We see that recovery is an important and fundamental phenomenon. . . . Although
the phenomenon will not fit neatly into natural scientific paradigms, those of us
who have been disabled know that recovery is real because we have lived it.
—Patricia E. Deegan, 1988
We envision a future when everyone with a mental illness will recover.
—U.S. Commission on Mental Health, 2003
Culture, Medicine and Psychiatry 29: 379–413, 2005.
c© 2005 Springer Science+Business Media, Inc.
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INTRODUCTION
As these epigraphs illustrate, there has recently been a paradigmatic shift in the
history of scientific expectations for the course of schizophrenia. Once typically
regarded in psychiatry as an inherently chronic and deteriorating condition, cur-
rent expectations concerning the course of schizophrenia-related conditions are
more sanguine than conceptualizations of such problems a century ago. In tracing
this extraordinary development, there are several issues to take into account. First,
transnational studies have empirically demonstrated that course varies worldwide
and that culture accounts substantially for much of this variability (Bebbington and
Kuipers 1994; Hopper 2004; Jablensky et al. 1992; Warner 1994). Second, long-
itudinal and neurocognitive studies alike have demonstrated that schizophrenia-
related disorders are not invariably deteriorating, chronic conditions (DeSisto et al.
1999; Good 1994; Harrison et al. 2001; Lieberman 1999). Third, the introduction
of the atypical (also termed second-generation) antipsychotic medications has
led to significant symptomatic improvement (Breier et al. 2000; Lieberman et al.
2003). Fourth, an increasing emphasis on the subjective experience of persons with
such conditions has suggested particular dimensions of recovery for investigation
(Hogarty et al. 1997; Jenkins and Barrett 2004; U.S. Department of Health and
Human Services [USDHHS] 2003). Finally, there has recently been a methodologi-
cal drive in the health sciences toward evidence-based approaches that incorporate
qualitative methods and narrative analysis (Davidson 2003; Frese 2001; Good
and Good 2000; Greenhalgh and Hurwitz 1999; Jenkins 1997; Kleinman 1988;
National Institutes of Health 2001). These convergent developments, taken to-
gether, argue for studies that can empirically specify illness processes of exacer-
bation, improvement and recovery. This article examines this problem on the basis
of a qualitative–quantitative anthropological investigation of cultural, psychoso-
cial, and pharmacological factors that figure into these processes.
A recent U.S. mental health report (U.S. Department of Health and Human
Services [USDHHS] 2003) defines recovery as “the process in which people are
able to live, work, learn, and participate fully in their communities. For some
individuals, recovery is the ability to live a productive life despite a disability.
For others, recovery implies the reduction or complete remission of symptoms.”
The concept of recovery has been conceived (1) as a process, outcome, or both
(Liberman and Kopelowicz 2005; Mueser et al. 2002) and (2) along a continuum
from more objectively to more subjectively based indicators of outcome (Liberman
et al. 2001; Ridgway 2001; Turner-Crowson and Wallcraft 2002). While both
kinds of data are ideally collected together, at this juncture it is remarkable that
systematic qualitative studies based on large sample size have not been available.
This study sought to address this shortcoming in the literature and is necessary to
identify the shared and distinctive social and cultural contexts in which recovery
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is transacted (World Health Organization [WHO] 2001). This gap in the health
and social sciences literature is particularly noteworthy when one is seeking the
perspectives of patients, families, advocacy groups, and mental health practitioners
(Jacobson 2001; Jenkins and Schumacher 1999; Turner-Crowson and Wallcraft
2002).
Narrative studies have highlighted the significance of the self as a dimension of
recovery. Davidson and Strauss’ (1992) discussion of the “work of recovery”
focuses on the reconstruction of an enduring sense of self. Davidson (2003)
employs a phenomenological approach by highlighting first-person accounts of
recovery. Despite the misperception that people with such illnesses are presumed
to be less articulate, less verbal, and less socialized than other adults, Davidson
avers that “schizophrenia provides a particularly appealing and potentially quite
useful area for qualitative research” (9). His research underscores the diversity
of experiences of schizophrenia and a full range of outcomes following a first
episode of psychosis from a ethnopsychological model implicitly based on North
American and European ethnopsychological selves (41).
To expand this approach to person-centered subjective perspectives on illness
recovery with a cultural approach, an anthropological perspective need be brought
to bear (Jenkins and Barrett 2004). An explicitly elaborated cultural approach
to recovery is critical since empirical studies have established the role of cul-
ture in shaping not only symptomatology (Barrio et al. 2003; Lin and Kleinman
1988; WHO 1979), but also course and outcome (Bebbington and Kuipers 1994;
Hopper 2004; Jenkins 1988b; Jenkins and Karno 1992; Karno et al. 1987; Leff
and Vaughn 1985; WHO 1998). We argue that the process of recovery can be un-
derstood in relation to what Obeyesekere (1990) has termed “the work of culture,”
by which is meant the subjective process “whereby symbolic forms existing on
the cultural level get created and recreated through the minds of people.” This
approach theorizes culture as both process and context of meanings that people
create in the process of social interaction (Floersch 2002; Ortner 1996). In this
way, self-processes in the “work of recovery” invariably involve the “work of
culture” as cultural symbols (for example schizophrenia, conceived as a relatively
nonstigmatizing condition such as nervios among Mexican-descent families [see
Jenkins 1988b] or as a chronic disease or personality deficit such as “laziness”
about which Euro-American kin are angry [see Jenkins 1988a]) that affect course
of illness.
Pharmacological treatment through “atypical” or second-generation antipsy-
chotic medications over the past two decades has resulted in the reduction of
both psychotic symptoms and extrapyramidal effects relative to psychotropic
drugs previously available (Awad and Hogan 1994; Weiden et al. 1996). These
medications (including clozapine, olanzapine, quetiapine, and risperidone) may
be efficacious with treatment-refractory patients as well as recent-onset patients
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as an initial treatment that may result in a better long-term outcome (Andersson
et al. 1998).
For some cases of schizophrenia, there were reports in the 1990s—in both the
popular press1 and the scientific literature—of substantial improvement and re-
covery on the order of the “awakenings” phenomena described by Sacks (1990)
for survivors of encephalitis. These accounts of significant recovery among the
previously persistently ill treated with newer medications have been heralded
in the Harvard Review of Psychiatry by Duckworth and colleagues (1997), for
example, as “often involv[ing] a fundamental reassessment of one’s identity, re-
lationships, and purpose in being. . . . The psychological reaction to dramatic
pharmacological response is largely uncharted territory” (55). Reports of such
dramatic changes in the subjective reactions and social relations of patients must
be subjected to empirical scrutiny, however, since they are part of a clinical narra-
tive premised on “miracle cures” and “wonder drugs” with a history in psychiatric
discourse of initial hope and fervor, on the one hand, only to be followed by
disappointment and subsequent discounting, on the other (Weiden and Havens
1994). As Hopper (2002) points out, sanguine, heroic stories of recovery may
be inconsistent with the “‘messy work’ of putting disrupted lives back together
again” (198).
Description of the SEACORA Study
This article reports on a NIMH-funded anthropological study, Subjective Expe-
rience and the Culture of Recovery with Atypical Antipsychotics (SEACORA),
that contributes to the specification of the subjective experience and meaning of
improvement and processes of recovery. The design of the study was a cross-
sectional assessment of community outpatients through combination of standard
clinical instruments (SCID-IV, BPRS, SANS) and qualitative techniques of inter-
viewing and ethnographic observation. Informed consent was obtained in line with
requirements of human subjects’ protection. A specific interview, the Subjective
Experience of Medication Interview (SEMI), was developed for this study, as an
open-ended narrative exploration of everyday activities, dating, gender identity,
social relations, medication and treatment, management of symptoms, expecta-
tions concerning recovery, stigma, and quality of life. Typically two interview
periods (ranging one to two hours in length over one to three interview ses-
sions) were carried out to complete the SEMI. Our central research questions
are:
• What is the subjective experience of taking second-generation antipsychotics
for patients with schizophrenia and schizoaffective disorders?
• What are the personal and cultural meanings of these medications from patients’
points of view?
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In addition to investigating recovery, the research was designed to expand on
customary studies of medication characterized by many professionals as medica-
tion “compliance” or “adherence” from the perspectives of persons actually taking
antipsychotic drugs (Budd et al. 1996; Hogan and Awad 1992). More broadly, this
ethnographic study sought to provide an anthropological account of their everyday
lived experience in the community.
We briefly outline the ethnographic context of this study. We worked at two
outpatient psychiatric clinics in a major metropolitan area in the northeastern
United States populated predominantly by people of European American and
African American ancestry. The city is one whose mental health care establishment
pioneered the use within the United States of clozapine, one of the earliest of the
so-called atypical antipsychotic medications. Patients spent varying amounts of
time in the clinics, and this was directly a function of which of the two clinics
they attended. In the first, originally set up as a research site for clozapine, patient
interaction was fairly intense, including daily visits during which they engaged
in a variety of informal social activities, with occasional group discussion on
topics of interest, guided by a nurse at the clinic. In the other, an older community
mental health clinic with a less developed research focus, patients came briefly for
biweekly or monthly medication checks. Although there may be a more fervent
and explicitly elaborated psychiatric ideology regarding the efficacy of medication
to treat disorders of the brain in the clozapine clinic, the primacy of medication as
the most important treatment was common in both settings as indeed is currently
the case widely throughout the country.
In briefly summarizing this research environment as an ethnographic setting, we
note first an ambiguity in the sense that, properly speaking, schizophrenia patients
do not constitute a community, although to some extent a clinical culture may be
constituted in and outside the treatment setting in which outpatients interact with
one another, and that insofar as patients talk among themselves based on common
experience they share minimal elements of what sociolinguists call a speech com-
munity. For the most part psychiatric outpatients must be understood in relation to
the ways they relate to the larger community, and in a major metropolitan area this
community is far from homogeneous. At the same time there are certain modes
of behavior common among patients, such as using public transportation and fre-
quenting establishments such as fast food restaurants. We are currently working
through observational data collected when project ethnographers followed patients
into their homes and such community settings, as well as conducting comparative
analyses along a variety of dimensions of patients treated in the two different clin-
ical settings. In this article, we concentrate primarily on data from ethnographic
interviews.
Transcripts of the SEMI were analyzed by the authors using an inductive ap-
proach to identify themes related to improvement and recovery. Improvement in
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relation to atypical antipsychotic medications was coded for all participants and
good (κ = 0.69) interrater reliability was established for the coding schema. For a
detailed exposition of coding procedures please see Jenkins et al. (2005). Analy-
sis of the SEMI also yielded many nuanced themes in relation to recovery, which
were subsequently established through consensus between the authors. This article
addresses both broad and subtler dimensions of recovery.
Methodological Orientation
In this article we focus on recovery from the point of view of persons diagnosed
with schizophrenia-related illnesses. We attend to recovery as a process through
a cultural approach that emphasizes both subjective experience and meaning.
First, attention to subjective experience foregrounds “the active engagement of
subjects in processes of cultural construction” (Jenkins and Barrett 2004: 9).
Second, we take a meaning-centered approach as developed by Good and Good
(1981) as a means to access and interpret personal and cultural understandings of
recovery processes. This approach is new in the burgeoning scholarly literature on
“recovery,” which has already been substantially advanced through distinctions
between recovery as process and recovery as outcome and, specifically, as one
that requires, as Liberman and Kopelowicz (2005: 740) term it, “social validity”
that urges a more expansive definition of recovery to incorporate a range of social
norms, standards, and expectations. We urge that this be expanded further to
locate explicitly the problem of recovery also to include prominently the cultural
milieu in which the process is mediated. Thus, the meaning of recovery, from
the perspective of persons actually engaged in the process, is constituted by both
shared and personal meanings. Meaning-centered approaches seek to identify and
to understand what is “at stake” (Kleinman 1999) for particular people at particular
times in particular circumstances.
Sample Selection
Subject selection criteria included the following: (1) a diagnosis of schizophrenia
or schizoaffective disorder assessed through the Structured Clinical Interview for
DSM-IV (SCID) (First et al. 2002); (2) age 18–55; (3) elapsement of at least two
years since first psychotic symptoms; (4) at least six months of treatment with
an atypical antipsychotic; (5) absence of comorbid substance abuse or organic
impairment; and (6) clinical stability sufficient to provide informed consent and
participate in interviews.
The complete rosters of two community mental health outpatient facilities in
a metropolitan area of the United States were obtained. Subject eligibility was
assessed by treating psychiatrists and individual therapeutic managers to create
a complete listing of all patients who met research diagnostic criteria. From this
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complete listing, participants were then randomly sampled. When individuals did
not meet the study criteria after administration of the SCID, or refusal to participate,
these individuals were replaced by the next person on an SPSS-generated random
sample listing until the desired sample (N = 90) was obtained. Toward the end
of the recruitment process, an attempt was made to include subjects such that
a balance would be achieved by sex and ethnicity across the two participating
clinical sites. From the list of randomly selected subjects who met the inclusion
criteria (167 subjects), 90 (54 percent) of those selected were included in the final
sample, with 46.7 percent of these subjects refusing research participation. The
overall high rate of refusal is not unusual for an American community outpatient
sample such as this, with males (55.9 percent) significantly more likely than
females (29.3 percent) to refuse participation (Fisher’s exact, p < 0.001). Reasons
for nonparticipation included general lack of interest in research (subjects stating
simply that they “didn’t want to”) and a reluctance to provide time for interviews
(due to work scheduling or preferences to spend time otherwise). In this light, it
is likely that those who did participate in the study differed insofar as they were
more motivated to participate in research, occasionally stating that they had an
interest in contributing to anything that had potential to help in the understanding
of others (or themselves). In this way, the sample may be more cooperative, be
more functional, or have a better treatment experience than those in the group who
declined research participation (as summarized in Jenkins et al. 2005).
RESULTS
Sociodemographic and Clinical Characteristics
Ninety persons participated in the study. Table 1 presents sociodemographic char-
acteristics of the sample. These recruitment criteria (e.g., no comorbid substance
abuse), sampling technique, and sociodemographic characteristics have been fully
summarized elsewhere (Jenkins et al. 2005). The sample consisted of 49 (54.4 per-
cent) men and 41 (45.6 percent) women. While most (84.4 percent of the sample
overall) were never married, significantly more men (95.9 percent) than women
(70.7 percent) had never married (Fisher’s exact, p < 0.01) and more women
(19.5 percent) than men (2.0 percent) lived with a partner/spouse (p < 0.01).
Relatedly, 17.8 percent had children, with more women (36.6 percent) than men
(2.0 percent) having children (p < 0.001). Overall, 40 percent of participants were
working in half- or full-time employment. On the basis of years of education and
occupation, there was a full range of social position within the sample, although
the majority (73.3 percent) was of middle- and upper middle–class background,
which is roughly representative of the sociodemographic characteristics of the
mental health catchment area served by the community health clinics. There were
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TABLE 1
Sociodemographic Characteristics of SEACORA
Participants (N = 90)
Number Percent
Gender
Male 49 54.4
Ethnicity
Euro-American 70 77.8
African American 20 22.2
Mean age (SD) 40.7 (7.9)
Mean years of education (SD) 13.0 (1.9)
Marital status
Single 76 84.4
Married/partner 5 5.6
Divorced/widowed/separated 9 10.0
Living situationa
Alone 23 25.6
Roommate 5 5.6
Group home 15 16.7
Relative/parent 38 42.2
Partner/spouse 9 10.0
Have children
Yes 16 17.8
Work situation
Not working 54 60.0
Half-time or less (<20 h) 20 22.2
Half- to full-time (≥20 h) 16 17.8
aDue to rounding, total percent may not equal 100.
no significant differences in socioeconomic status (SES) by gender or ethnicity
(Euro-American or African American).
Table 2 lists the clinical characteristics of the research participants. The
majority (81.1 percent) were diagnosed with schizophrenia, with 18.9 percent
diagnosed with schizoaffective disorder. As has often been noted in the literature
(Goldstein 1988), women (M ± SD = 22.6 ± 9.1) had a later age at onset than
men (M ± SD = 18.9 ± 4.9; t = –2.34, df = 88, p < 0.02). The mean years of
illness was 20.1 (SD = 8.4). The majority (56.7 percent) were taking clozapine
as their current atypical antipsychotic medication. Other participants were taking
risperidone (17.8 percent), olanzipine (16.7 percent), or other investigational
(8.9 percent) atypical antipsychotic medications. Brief Psychiatric Rating Scale
(BPRS) factor scores showed remarkably low levels of current symptomatology
in the sample overall (Jenkins et al. 2005).
The particular sociodemographic and clinical characteristics of our study par-
ticipants suggest that, relative to other community populations, our sample may
be “doing better” than those who have less access to psychiatric care, financial
resources, or family support or than those who also have comorbid substance
THE NEW PARADIGM OF RECOVERY FROM SCHIZOPHRENIA 387
TABLE 2
Clinical Characteristics of SEACORA Participants (N = 90)
Number Percenta
Diagnosis
Schizophrenia 73 81.1
Schizo-affective 17 18.9
Mean age at onset (SD) 20.6 (7.3)
Mean years ill (SD) 20.1 (8.4)
Admissions
Mean (SD) 7.0 (7.0)
Median 5.0
Range 50.0
Outpatient treatmentb
Mean (SD) 7.6 (4.5)
Median 7.0
Range 20.0
Current atypical antipsychotic
Clozapine 51 56.7
Risperidone 16 17.8
Olanzapine 15 16.7
Other 8 8.9
BPRS subscores M ± SD
Thought disorder 1.9 ± 0.88
Withdrawal 1.9 ± 0.54
Anxiety/depression 2.4 ± 1.0
Hostility/suspicion 1.7 ± 0.65
Activity 1.2 ± 0.32
aDue to rounding, percent may not equal 100.
bLength of treatment at current clinical site in years.
abuse (the latter were excluded from the present study, which seeks to examine
subjective experience of medications only, uncomplicated by such street drug use).
Specifically, given the relatively high SES, proportion of the sample working, and
available social support, as well as low levels of symptomatology that characterize
participants in this study, we might expect this to be a particularly “improved”
or “recovered” sample. Yet we are not inclined to consider these contextualizing
features to be a limitation of the study. Rather, we find it notable that even among
those who may arguably be “doing better” relative to their counterparts in the
community, recovery is still fraught with deep personal and cultural ambivalence
in ways (specified below) that remain highly problematic.
“Awakenings”
In this study, the experience of an “awakening” was reported if, in response to
a direct interview question or spontaneously, persons made a narrative statement
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during the SEMI to indicate that they had experienced a subjective sense of sub-
stantial and global transformation from a previous illness state. Only a minority
of participants (n = 22, or 24.7 percent) reported having experienced an awak-
ening, and among this group no one reported that this state had been sustained
beyond a period of what they recall as a few weeks or months. Individuals with a
schizoaffective diagnosis were significantly more likely (Fisher’s exact, p < 0.03)
to report having experienced an awakening (8 of 17) than those with a diagnosis of
schizophrenia (14 of 72). For the proportion reporting an awakening, no significant
differences were observed for gender or ethnicity.
Subtypes of awakenings were coded as “phenomenological” and “social.” A
phenomenological awakening was defined as the report of a substantial change
in perception of one’s reality, as in “coming out of a fog” or experiencing the
world in a dramatically different manner. Of the 22 individuals who reported
an awakening, 18 reported a phenomenological subtype. Below is an example
described by a participant:
It’s kind of hard. It’s like trying to describe the color blue to someone who has never had
sight. You know what blue is but you don’t know how to say it to make them understand. . . .
I just know that I’m benefiting from the way I am now versus the way I was before . . . now
I know what reality is.
In contrast, a social awakening was defined as a substantial change (improve-
ment) in relationships with family, friends, or other individuals. Four individuals—
all women—reported this type of awakening, to highlight their sense of substantial
improvement on the order of an awakening involving a strong, previously unre-
alized awareness of connection to family and friends. Although the number of
respondents reporting a social awakening is small, it is noteworthy that phe-
nomenological awakenings were split nearly evenly between men and women,
with only women reporting the social subtype.
The Incremental Nature of the Process of Improvement
Narratives of improvement and recovery in association with the metaphor of
awakenings appeared only among a minority of the SEACORA participants, who
generally noted that such states were not sustained over time. Nearly all empha-
sized that the processes of illness management and improvement were gradual.
Furthermore, these processes were subjectively observed as not necessarily a lin-
ear progression but rather one with occasional setbacks inherent to the process.
Even so, when this North American sample was asked whether they expected
the course of their illness to get better, stay the same, or get worse, the majority
(80 percent) heartily expected their course of illness to improve. In response to
a broader question of whether they expected their lives to get better, worse, or
stay the same, most (70.6 percent) also conveyed that they indeed expected their
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lives to get better. The rest thought that their illness would stay the same (14.1
percent) and their lives were likely to remain the same (25.9 percent). Strikingly,
only a few expected that their illness would probably become worse (5.9 percent)
and their lives likewise (3.5 percent). Our primary finding can be characterized
through an understanding of recovery as an incremental process of improvement
that occurs gradually, and is experienced subjectively over days, months, and even
years. A narrative illustration of the central role of suffering (Kleinman 1999) in
processes of recovery was widely evident in subjective comparisons to a previ-
ously severe and continuous illness state as expressed in the following narrative
excerpt:
See, I’ve tried to explain in my poetry about how horribly suffering the psychosis is when
you’re in it, and I can’t find the poem. There was a contest—today was the deadline. I
sent some other poems, but I wrote this one poem saying that when I’d gone psychotic,
the agony and the suffering would make Christ look like a teenage girl in bobby socks
and saddle shoes and the Catholic girl skirt, with white blouse sitting at the drugstore soda
fountain. [No. 63]
In sum, the phenomenology of recovery—following extraordinary suffering—
can be best characterized as a slow, incremental, but definitively discernible sub-
jective process of improvement.
Experience with and Faith in Medication as the Key to Improving
Considering the total sample of 84 participants who were taking atypicals after
having taken older antipsychotics, the majority (77.4 percent) noted improvement,
whereas 10.7 percent experienced no improvement. Some (8.3 percent) of the
responses were contradictory or ambiguous and could not be coded owing at times
to the lack of enough data to say in either case. Of the six persons who had received
an atypical as their first medication and therefore had no basis for comparison
between older and newer antipsychotics, five (83.3 percent) nonetheless affirmed
that they had faith that the medication contributed to their improvement (Jenkins
et al. 2005). One participant maintained that the medication provided a gradual
improvement over time and that, for this reason, he took it “religiously.”2 There
were no significant differences in these subjective reports in relation to clinical or
sociodemographic characteristics.
While our African American subsample was not large, there was a tendency
within that group to be even more likely to narrate improvement through medica-
tions than Euro-Americans. However, the overall subjective sense of the prominent
role of medications to improvement was striking. Indeed, medication occupies
the most salient narrative position in the subjective sense of incremental recov-
ery. The usually long (several years) and excruciating process of trying a series
of medications was typical in this sample of persons who had struggled with
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schizophrenia-related conditions for two decades (Table 2). Within these bio-
graphical contexts, recovery was often relativized in relation to the severity of the
illness previously in one’s life.
Improvement through “Personal Power and Control”
While medication is given a primary narrative placement in processes of recovery,
many participants were convinced that medication could not be relied on for all
of the “work of recovery.” The narrative data in relation to felt personal power
and control showed that half (51.1 percent) experienced having the capacity or
will to struggle against the effects of illness. Those who felt they had “personal
power and control” made clear that although medications enabled them to improve
substantially, they must also do personal “work” as crucial to improvement and
recovery (Davidson 2003; Strauss and Carpenter 1977). Among those who expe-
rienced comparatively higher clinical and social functioning, the role of sustained
effort was often inexorably linked to social engagement, that is, personal efforts
were strongly contingent on engagement in social relations (Jenkins et al. 2005).
“Controlling” the Illness through Medication
One significant dimension of recovery is a cultural orientation to control.3 In this
U.S. study, the theme of control has an array of quite different subjective mean-
ings as these are variously invoked across individuals: control over symptoms
surrounding thought, emotion, and behavior, control over life circumstances, con-
trol over hospitalization, control in social encounters, and control over appearance
and self-presentation. In this study, however, the narrative data highlight persons’
commonly shared sense that medication is the most important factor in relation to
gaining control over such problems for the self:4
I think it’s under control now because of the medication. I think it’s part of the Clozaril—
I wasn’t able to control it, even if I wanted to I couldn’t. And uh . . . I think the most
important thing is finding the right medication that starts to interact with the illness. And
it just takes a long time. You know, you have to be willing to invest the time, you know,
taking medications and waiting for it to . . . ‘cause you can try—I mean I was on a number
of medications, and they didn’t do anything for me. So it’s—I think the first thing is trying
to find the right medication, and then that can take a long time. It took a long time for me
to finally find a medication. It took like eight years. [No. 76]
Thus regularly taking medications—with the help of a compatible doctor—
is one means for engaging the struggle to recover from schizophrenia. Several
studies have shown that regular medications and treatment can dramatically reduce
symptoms, relapse, and rehospitalizations (Lieberman 1996; USDHHS 1999).
“Controlling” the Illness through Activity, Leisure, and Distraction
Control of the illness involves other strategies as well, however, such as efforts to
“keep busy,” to relax, and to distract oneself from otherwise disturbing symptoms.
THE NEW PARADIGM OF RECOVERY FROM SCHIZOPHRENIA 391
R: It’s better for me most of the time to keep busy, although, I need a little bit, or a bit or
some time to myself. Where I can just sleep, or rest, or relax, just let myself do nothing
or just about nothing. Any little bit at a time, I’m in that. But for the larger part, the
largest part is keeping busy, and I keep busy.
I: How do you think that helps you with your illness?
R: Uh, well, it keeps me occupied, and keeps me, helps me check on my energy, and, uh . . .
uh, I don’t know if you would call it a distraction from my own thoughts and feelings,
or what you would. I’m not saying I’m trying to run away by doing these things. I
assume some people might look at it that way, you know. . . . But I think, if you’re doing
something constructive and useful with all that, it has positive value to it, you know. [No.
03]
In addition to the role played by “everyday” sorts of distractions, others highlight
the importance of religion in tandem with personal effort to control the illness:
Well, when I hear the voices, there’s a combat in my head. You know, there’s a struggle.
And I have to fight ‘em. And if I just go with the medicine, it doesn’t work. You know, it
takes, actually distracting myself and making the effort and cooking the meal, and sitting,
trying to sit still and watch TV and going for a walk, that . . . ‘cause if I just lay down, they
won’t go away. Until I fall asleep. . . . Also, going to church gives me spiritual strength,
because when I didn’t, it was worse. My whole life was worse when I didn’t go to church
and follow the, walk with the Lord. [No. 27]
Diet and exercise, along with avoiding street drugs, are also noted as being
important for health:
There’s things you can do like I try taking an eight mile hike everyday. It makes you
feel good physically, and in turn you feel better emotionally and mentally. Ah . . . eating
on a regular basis as opposed to eating one fast food meal a day and then just going on
caffeine and nicotine. The little stuff like that really adds up. . . as far as the power of
positive thinking can affect it—no not really because it’s . . . you can’t maintain positive
affirmations 24 h a day around the clock. I think that doing things that anyone could do
for themselves regardless of whether they are schizophrenic or not can affect your health.
Then there is the obvious staying away from drugs . . . but again that’s something you have
to do. [No. 66]
While the foregoing factors are cited as part of a daily process for control of
the illness, “control” is enacted in highly personal ways in relation to individual
needs and desires.
Self Processes in Relation to Recovery
Among participants, their experience can be characterized as a palpable struggle
to situate themselves relative to their illness and medications. For participants,
negotiating a sense of self involves teasing out the effects of their medication,
symptoms of their illness, and aspects of their personality. This personal project
simultaneously manifests and mediates the overlapping and polysemous mental,
physical, and emotional dimensions of the perceived transformative process of
recovery. Rendering the self entails both explicit and tacit negotiation of a sense of
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“me” versus “not me.” In contrast to previous studies (Estroff 1989) we do not, in
the main, find among participants a fixed location for their subjective experience
of illness identity. Instead, self processes among participants involve a substantial
struggle and may be characterized as shifting and porous.
Personal Agency and De-emphasizing of Mental Illness
In the classic anthropologically informed formulation of psychiatric disorder as
invariably located within particular social interactions, Harry Stack Sullivan (1962)
set forth schizophrenia as a problem characterized by awareness and management
of fragile self processes in specific situations. Our ethnographic data show that
persons participating in the study often characterize their illness management as
one in which medication cannot possibly be expected to do all of the complex and
subtle “work” involved in the process of recovery. Numerous capacities of the self
were invoked under a broad cultural framework of “control” with illness-specific
concerns intersecting with “everyday” problems of making one’s way in the world.
Many persons developed psychocultural strategies for struggle and control not
through overcoming the illness or “fixing” the illness but, rather, through accom-
modating the illness. An accommodation or learning orientation to recovery stands
in contrast to a problem-oriented approach that situates the illness as an enemy
in relation to the self. Instead, by learning to deal with extraordinary experiences,
both the illness and the self may be redefined in relation to one another. This re-
definition may involve a conscious decision by individuals to adopt an affirmative
perspective on their life circumstances. Some participants specifically reject view-
ing their lives or illnesses in negative or deficient terms. One person, for example,
was adamant that despite the many difficulties she faced, she “liked her life,”
taking a directly offensive position to counter others who, from her perspective,
appeared to view her situation as dismal. In another example, one person described
how she accommodated the illness by allowing herself to experience symptoms:
I: So, do you feel like you have any personal power or control over your illness?
R: Yeah I do.
I: Yeah? How is that?
R: Because I can control the way I think.
I: Uh hm. And what do you try to do when you control what you think, how does that
work?
R: Like, if I have a sick thought or something, I’ll just allow myself to have the sick thought.
But I’ll recognize it as a sick thought. [No. 54]
In the above example, this person has taken an active stance in relation to her
symptom experience. Instead of being a passive recipient of “sick thoughts,” she
chooses to recognize herself as an agent of those thoughts. By turning the tables
on her symptoms, she acts as the author of her thoughts, manifesting control in
both the act of thinking and the recognition of certain thoughts as problematic.
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In this way, the illness is not external to the self for this participant but, rather,
is incorporated into it as an aspect of self-experience. She experienced it as the
re-creation of a new self.
“Normalizing”and “Relativizing” Illness
Normalizing the illness is achieved through strategies that situate the illness in
relation to an integrated self-concept and engagement with the world. Recovery,
for some participants, was experienced as a return to normality or to their “old
selves.” Returning to an “old self ” or the creation of a newly reintegrated self
suggests that persons develop a narrative strategy, creating an opposition between
the ill (former) self and the recovering/recovered self. This opposition is also
borne out in the strategy of relativizing the illness. The temporal dimension of this
strategy is elaborated by participants who compare their current situation to the
past, before the use of atypical antipsychotic medications.
Relativizing the illness is not limited to one’s relationship to the ill self, but
also occurs in relation to others. Like all persons, individuals with mental illness
evaluate and assess their own behaviors through comparisons with others. This
person distinguishes herself both temporally from her ill self and also from others
with mental illness:
I think the hardest thing for people with mental illness to do is to socialize and make friends.
A lot of people with mental illness don’t have good social skills. I have good social skills
now but I never used to. [No. 25]
Similarly, one person reflects on his frustration with being associated with other,
lower-functioning individuals with mental illness:
Well, what they do is they bring these mentally ill people all together. And they bring them
together and expect you to be friends. Just because of your illness. But there’s much more
to friendship than just sharing an illness. And I totally disagree with what they do, with
bringing people together. It’s very frustrating to me. ‘Cause these people are all functioning
on different levels. I’m on a pretty high level. A lot of these people in the program are
pretty low functioning. And you know, they put me in there and expect me to gel with these
people. I just can’t do it. It just doesn’t work. So I avoid them as much as I can. I play
tennis with them on Sundays, you know. That’s not that bad, but other than that, I kind of
keep my distance. [No. 76]
In the above example, relativizing cuts doubly, functioning positively as a nar-
rative strategy for recovery, but also serving to reproduce the stigma associated
with mental illness through the creation of an “us” and “them” opposition. As
such, stigma takes on a complex relationship to individuals with mental illness,
as something to be managed as well as something capable of being co-opted
by individuals with mental illness to perform the cultural work of recovery. In-
dividuals co-opt and reproduce stigma through a narrative strategy that places
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the ill self in opposition to the current recovering self, as well as drawing the
distinction between the self and others who are less recovered. In expanding on
Goffman’s (1963) classic formulation, sociologist Link and colleagues (2001;
Link and Phelan 2001) argue that the social and cultural study of various forms of
stigma and the pernicious effects they produce in the case of mental illness is an
especially critical research priority.
The Solace of Others
It is evident that recovery extends beyond transformation of the self and negoti-
ation of personal identity “that combines the intimate or personal world with the
collective space of cultural forms and social relations” (Holland et al. 1998: 5).
Participants were often significantly supported by kin, friends, and health care
providers in their struggle to recover. The types of interactions that appear to be
helpful are remarkable for being utterly ordinary, illustrating that it does not re-
quire exceptional efforts to offer substantive support. In fact, such “everyday” and
“normal” forms of connection may be some of the most important for the recovery
process, allowing the individual to be treated as “just another person” rather than
being marked as ill and excluded as such. This can be an effective counterweight
to stigma, though not all social contact—including that with kin—is salubrious.
Living situation is one proxy of social contact and possible support. In this study
(Table 1), the highest percentage of participants (52.2 percent) lived with family.
One participant, a 27-year-old Euro-American man, describes his relationship with
his mother in this way:
B: Do you, um, do you take care of your mom, would you say?
R: Well, I think we take care of each other. We have a very mutually supportive relationship.
She’s the reason I’m still here. [No. 01]
His mother was a very visible part of his everyday life and deeply involved in
his recovery process, taking on the role of personal advocate for her son as well
as being active within the National Alliance for the Mentally Ill (NAMI). A
26-year-old Euro-American woman identifies her brother as her “closest friend.”
In the following narrative example she describes her brother’s role in caring for
her during her illness:
When I was sick, they—my brother watched me. They had to watch me, and he’d take off
work and stuff like that. [No. 27]
Her brother also makes it a point to include his sister in his social gatherings
or outings, such as going to the movies. Her experience speaks to the need for
support not only in the throes of an acute illness episode but also for continuing
support in the recovery process. As noted above, however, not all social contact
is positive. Decades of “expressed emotion” research have demonstrated that the
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emotional climate of the familial and social environment in which patients live can
have deleterious effects on the recovery process. It is therefore crucial to take into
account the quality of social interactions in the context of recovery (Bebbington
and Kuipers 1994; Jenkins and Karno 1992; Vaughn and Leff 1976). For example,
an African American woman in this study appeared to be quite sensitive to her
sister’s refusal to speak to her about her illness experience or to include her in
casual or intimate conversation alike. This seems to have had a negative impact
on her everyday life as well as fluctuations in her psychotic symptoms.
I: How do your friends, or say, [your sister] handle the problems that are associated with
your illness?
R: Well, what gets on my nerves with her [my sister] is, she thinks I’m going to break,
like everything. And it’s like I have problems, if it’s, when I do decide to discuss them
with her, it’s like she always tells me . . . to get that situation under control, you’ve got
to control it. Which I know that because, don’t get sickanymore, please don’t get sick
anymore. This mess, you think that everything is associated with me, and then I have a
problem. She thinks I’m going to break. I’m not china, I’m not going to break. I just want
to talk to you about what’s bothering me. But the minute I talk about what’s bothering
me, she brings up as though, as though she keeps reminding me that something’s wrong
with me, you know. . . . I’m not going to break. You know, make me feel like I’m so
fragile, that I can’t get, or understand anything, you know?. I have a lot of responsibility
and whatever. . . . But I’m not china. I mean, give me credit for something.
Responsibility for Others: Persons with Schizophrenia as Caregivers
In this study, we observed that, even among persons with mental illness, so-
cial support is a reciprocal process. It was striking that study participants took
care of others in a variety of ways, from more casual “checking in” on others—
roommates, friends, relatives—to being primary caregivers for elderly parents
in ways mundane and exceptional alike. The finding is somewhat surprising
given how little attention this social process has garnered in the literature. For
many, in addition to being substantially supported in their recovery efforts by
family and friends, they were also actively taking care of others, as illustrated
below:
Well, my thoughts now are more settled on, taking care of my mother and thinking about
how to take care of myself and what to do when she passes away. Um, taking care of the
car, and my entire life is focused on responsibilities, obligations, chores. [No. 87]
One participant describes daily involvement in helping his roommate to take
medications:
I: Besides taking care of your own illness, are you taking care of anyone else right now,
too?
R: Uh, kinda, yeah.
I: And who is that?
R: Um, my roommate. I get out his pills for him at night. [No. 11]
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Two other participants described their activities as parents:
I: And who else are you taking care of now? You’re (saying you are) always taking care
of somebody else?
R: Yeah, well . . . I, my son, he’s 19. I guess you say I look, I’m taking care of him, cause
um, I look after him. He tells me he’s a man, but I look after him since he was a little
kid. You know what I mean. I wash his clothes, I cook his meals. I even pick up behind
him. [No. 33]
I: Uh hm, sounds like you have a lot to take care of with yourself, is there anyone else that
you take care of too?
R: My daughter. She takes medication too. [No. 43]
These two narratives reflect the responsibilities of parenting, from the more
pedestrian “picking up” after (adult) children to monitoring their health status and
medication. Still other participants served as primary caregivers, describing this
as a “full-time job” in caring, for example, a nephew and niece in this case:
I: For now, can you tell me if, besides managing your own illness, if you’re taking care of
anyone else, too, right now?
R: Yes, I babysit my two, my uh, my nephew and my niece. My nephew is four years old
and my niece is one year old.
I: Uh hm.
R: I babysit them while both their parents work.
I: Okay.
R: They’re over our house during the day because both their parents work.
I: Uh hm.
R: This is usually, at least, well, it’s different every week. Some weeks it’s three days a
week, some weeks it’s two days a week, some weeks it’s maybe four or five days a week.
It all depends on how busy their parents are, how [stutter] much other things they have
to do when they can’t watch their children.
I: Okay. How long have you been doing that?
R: Uh, let’s see . . . ever since 1995.
I: Okay. And how many hours a day do you usually do that for?
R: Oh, maybe six or eight hours a day.
I: What kinds of things do you do when you’re babysitting?
R: Make sure they get fed, make sure they get their rest, make sure they have something to
do. See, they’re both very active so you’ve got to keep up with them, see. . . .
I: Uh hm.
R: The one likes to go outside and play in the backyard so my grandfa—my father and I
have to go in the backyard and play with them, you know.
I: Uh hm.
R: They keep you, you know, they keep you on your toes.
I: I bet.
R: Because, you know, you know, they are a handful, they always come in and want you to
do something with them so, so . . . you’re basically, it takes us full time. [No. 53]
Finally, one male participant describes in astonishing detail his responsibilities
in caring for his elderly mother:
I: Um, well, besides managing your own illness, I know you’re taking care of your mom
too right now. Um, can you tell me a little bit about what you do for your mom? What
kinds of things you do to help her?
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R: Well, the day starts out, I give her, I check her blood sugar, all, every other day in the
morning and then every other day in the afternoon. And then I fill up her syringe so she
can give herself the insulin shot. And I um, fill up the inhaler, it’s called a nebulizer
which um, the little, comes in a little vial. The um, albuteral. And that turns into a steam
mist which she breathes into her lungs. And so, I fill that up for her three times a day,
then I fix her breakfast, lunch, and dinner. And um, do her laundry and um, take her
um, prescriptions to the um, drug store when she needs those filled. And um, basically
whatever else she needs done, I do her grocery shopping. And um, it takes two of us
to take her to the doctor. My uncle um, comes and helps me, the wheelchair fits in his
car. I’ve got two uncles. Her sister and her sister’s- her brother, I mean. And her sister’s
ex, um, her sister’s husband. Her sister’s passed, so both of them help us take her to the
hospital and her doctor’s appointments.
I: Um, okay. Now, she has diabetes and pulmonary fibrosis and—
R: Rheumatoid arthritis, high blood pressure. Um, and um, now she’s got the hematoma.
She just recovered from having her artificial aorta put in. She has um, she’s had numerous
operations. Her wrist is wired together where it fell off when they were going to operate
on it, from the arthritis. She had shoulder spurs, so she had operation on her shoulder.
And um, she had operation on her knee, she can’t bend her knee. Uh, she’s got artificial
knee. And did I mention her Achilles tendon came off the bone, so it took a while for
that to knit together. She was in a wheelchair then. And now she’s on oxygen, I’m here
to let the oxygen man in. He comes in twice a week and pumps up her tank with liquid
oxygen. Tuesdays and Fridays. And um, basically that’s it. [No. 87]
The experiences of the individuals quoted above clearly illustrate the sometimes
mundane, occasionally Herculean responsibilities undertaken by participants on
a regular basis. While only 40 percent of the SEACORA sample were currently
employed, in our view, wage labor is clearly a limited yardstick by which to
assess either functionality or daily responsibilities. We advocate a more global
view of work in light of the many study participants who occupy a crucial position
within their families as caregivers for children and elderly parents. Although they
themselves may not be producing income, their labor is nevertheless, in many
cases, geared toward supporting the wage-labor of others.
It’s the Little Things: Joie de Vivre in Life and Recovery
As for the finding of significant social support being provided by persons in this
study, it is likewise remarkable how we have observed substantial joy in relation to
“small” and “everyday” pleasures. Again, this is typically thought to be a domain
of experience that is largely absent in the lives of persons with schizophrenia (see
Jenkins [2004] for a discussion of the “otherizing” of persons with schizophrenia
as “less than fully human”).
The danger inherent in overly formalized and rigid investigations into recovery
is overlooking the idiosyncratic—indeed, human—element in the experience and
expression of recovery. Patient/client–based definitions of recovery may involve
factors seemingly distant from the scope of mental health studies. As such, par-
ticular components of these definitions may overshadow the relative importance
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of medications, symptoms, treatment, and work outcomes. Recovery in this sense
creates an imperative to diminish the ideological, material, educational, and so-
cial gulf existent in the construct of “us”—as researchers and clinicians—and
“them”—as individuals with mental illness.
Expanding definitions of recovery to include “the little things”—elements of
the joie de vivre—demands at least a temporary decentering of the role of mental
illness in the lives and identities of individuals. One participant waxed eloquent
about “what he lives for:”
I: Well, how would you describe what you live for?
R: A twenty dollar bill. Um, a canoe trip in Michigan. Um, sunscreen at the Kmart down
in Florida. Uh, looking at quarters. Um. Tasting the ocean. Um. [pause] Birds.
I: Birds?
R: Birds, yeah. Birds chirping. Um—okay. Um. Being a good Christian, stuff like that.
[No. 40]
In contrast to the appeal of popular cultural discourses of overnight successes
and dramatic triumphs over adversity, the subjective experiences of participants in
the study speak to recovery as gradual and incremental, manifest in the mundane
facets of everyday life. While the cultural force of Hollywood-esque narratives of
“awakenings” is evident in participants’ dissatisfaction with clinical discourses in
their voiced desire for a cure, as opposed to management, for their illnesses, they
nevertheless engage with the work of recovery on a daily basis, confronting the
struggles and challenges of everyday life not uncommonly with steadfast fortitude.
Processes of recovery also hold implications for classical anthropological dis-
courses on transformative processes. The process of recovery as observed in this
study is by no means a rite of passage that produces a definitive transition from one
state to another. Instead, the subjective experience of participants calls attention
to the unfolding and partial character of daily rituals of recovery, often entailing
such pedestrian efforts as getting out of bed, meeting with friends for a cup of
coffee, taking care of others, and actively distracting oneself from annoying voices
by gardening. These are not dramatic and highly culturally elaborated ritual pro-
cesses, yet by engaging with the flow of daily life in such incremental and additive
rituals, participants become agents of their own transformation.
Cultural Conundrums of Recovery
Ironies and contradictions. In an overall analysis of participants of the SEA-
CORA study, several specific problems (Table 3) were identified as part of pro-
cesses of improvement to include cultural and structural conflicts that generate
the experience of ambivalence that we characterized analytically as the “paradox
of recovery without cure,” irreconcilable “catch-22” dilemmas involving sacrifice
whereby one must be “fat” (drool or have diminished sexual interest) in order not
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TABLE 3
Competing Discourses Create Cultural Pardoxes of Lived Experience
• Recovery without cure
• Stigma despite recovery
• “Crazy” or “fat”
• Sexless and genderless yet desire and gendered conflicts
• Social developmental problems yet pharmaceutical “management” without psychotherapy
• Fault-free “biochemical imbalance” yet characterological “defect”
• Felt need for medication in face of fears of addiction, toxicity, and chronicity
to be “crazy,” and confusion and stigma surrounding the meaning of living with a
“chemical imbalance” for which one is expected to take medication for the rest of
one’s life. The all too familiar dehumanizing of persons with schizophrenia that
leads to assumptions that they do not and should not date or be active sexually—
certainly not to reproduce—is noted by participants in the SEACORA study as
problematic. Many have, or would like to have, active sexual or romantic rela-
tionships and resent the subtle insinuation across a variety of social settings they
encounter that, unlike their counterparts, they should not be involved in romantic
entanglements, parental duties, or gendered identities.
Each of these ironies points to a direction for our continuing analyses of these
data, but for the moment we elaborate briefly on only the first of these issues, the
paradox of “recovery without cure.” Notwithstanding recent national and interna-
tional research reports, such as those noted earlier, for schizophrenia, unlike other
diseases, everyday clinical and popular discourse is notably silent or pessimistic
on the possibility of “cure.” The perhaps metaphysical longing for cure is experi-
enced as troubling to many in the SEACORA study, for whom “cure” was what
they deeply desired. The elusiveness of cure can be painful indeed.5
One Euro-American woman (No. 4) drew pictures of herself before and after
taking the newer medication. The last of the drawings was similar except for what
she called her “extra gut,” that is, the “sixty pounds she had gained on Risperdal.”
This self-drawing differed also from her earlier ones in that it did not have eyes—
she crossed them out and wrote “self blinding”—which she further narrated as
having “blinded herself to the fact that the medication could not ‘cure’ me.” In
another example, a Euro-American man conveyed his desire for and confusion
surrounding a “cure” for schizophrenia:
I’d like to be healthy and I’d like my illness to be in remission. And I’d like to be cured of
my illness if it’s possible, and, uh, if, to the best of my knowledge, is that there’s not a cure
for schizophrenia. But, like I said, it depends on the doctor’s philosophy, too. Some say
there are cures for all illnesses, some say there aren’t. And some say you can put illnesses
in remission, and cure them, so I don’t know.
For this group as well as others around the globe, medications alone simply
cannot be expected to produce a cure. In the present context, this problem is
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severe in contemporary psychiatric practice given the shortage of psychotherapy
for such persons; however, in addition to the limitations placed on psychiatrists by
managed care and insurance coverage for such services, also troubling has been
the longstanding clinical perspective that psychotherapy is, in any event, of highly
limited value for this population.
Processes of improvement as a moral “struggle.” The personal effort involved
in recovery can be considered a kind of “moral struggle” in which people en-
gage. The specific term struggle came up very frequently in the narrative data
from the SEMI, and the term moral we invoke here in the sense that Kleinman
(1999) uses it, as precisely “what matters” that provides experience with its moral
mode as “the medium of engagement in everyday life in which things are at
stake and in which ordinary people are deeply engaged stake-holders who have
important things to lose, to gain, and to preserve” (362). Since what matters
varies across diverse social settings, the moral modes of experience must vary, and
this is a fundamental implication of Kleinman’s contribution to moral theory—
as applied to persons who have suffered profoundly and are now engaged in
struggles long and deep to live under intersubjective conditions that alleviate
oppression.
The social life of medication and side effects. While a majority of persons
(77.4 percent) subjectively experienced improvement in association with atypical
antipsychotic medication, 90.8 percent of those experiencing improvement also
noted one or more distressing side effect that they felt was due to the medication
(Jenkins 2005). As reported in Table 4, participants considered the worst side
effects to be weight gain, drooling, and tiredness/drowsiness. Gender differences
were noted, with comparatively more women concerned about weight gain and
men with sexual dysfunction. Reports of no troubling side effects are particularly
noteworthy. Strikingly, 19.3 percent of the sample declined to cite a “worst side
effect.” This finding supports our sense that troubling side effects may have been
underreported by participants in relation to factors straightforward and inchoate
alike: (1) gratitude for medication for symptom control; (2) consideration that,
relative to typical antipsychotics they had been taking, they experienced better
symptomatic relief and fewer troubling side effects with atypicals, and thus deemed
them “better,” while also resigning themselves to a kind of relativistic “sacrificing;”
and (3) a sense of oppression as socially stigmatized persons insofar as they
did not feel “entitled” or morally worthy enough to launch complaints about
medications that were less than ideal. The finding that the vast majority felt
they must contend with serious side effects and yet remain committed to taking
these medications to avoid symptom exacerbation and hospitalization thus implies
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TABLE 4
Rank Order of Most Troubling Side Effect
(percent)a
Overall Male Female
(N = 88)b (n = 48) (n = 40)
Weight gain 18.2 14.6 22.5
Droolingc 17.0 14.6 20.0
Tired/drowsy 17.0 16.7 17.5
Tremor/stiff 10.2 10.4 10.0
Sexual dysfunction 5.7 10.4 0.0
Anxiety/fear 5.7 8.3 2.5
Gastrointestinal 3.4 4.2 2.5
Blood draws 3.4 2.1 5.0
Noned 19.3 18.8 20.0
aTotal percent may not equal 100 due to rounding.
bN < 90 due to nonresponse.
cDrooling reported significantly more for clozapine
patients (Fisher’s exact, p < .001). No significant
differences by sociodemographic or other clinical
variables.
dResponse of “none” sometimes accompanied by
statements such as “relative to older meds.”
substantial ambivalence and contradiction in the face of this predicament. This
problem complicates the meaning of recovery.
The study of medication experience must be expanded to go beyond the standard
side effects typically listed in the pharmaceutical literature (and studied in clinical
trials), to incorporate a great many other “effects” that alter subjective experience
in a myriad of ways and entail sacrifices in the context of self-presentation and
social interaction across a variety of settings. Recovery often involves negotiating
the “catch-22” of the necessity of medication with the embarrassment of its effects.
Effects of the medication, in this sense, must be understood more broadly to include
the influence of medications on one’s way of interacting with and inhabiting the
world.
Stigma despite improvement. As just outlined, improvement is a welcome expe-
rience relative to prior states of severe illness. Nevertheless, a pervasive problem
faced by persons in the study was the dilemma of finding themselves the object
of substantial social stigma despite their subjectively experienced improvement.
Nearly all (96.0 percent) reported their experience of stigma daily across a vari-
ety of social settings. In this way, socially and culturally produced stigma, like
the disease of schizophrenia, is a potent force against which they must strug-
gle vigorously. This is true even though most subjects appear to endorse the
notion that they have a “biochemical imbalance” that culturally is theoretically
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“fault-free.” Rather, many participants in the study apparently felt that having such
an “imbalance” rendered them deficient, flawed.
De-emphasizing the illness offers a strategy in the management of stigma.
Through normalizing and relativizing the illness, individuals may take an active
stance against stigma. Participating in such a stance engages multiple psychocul-
tural arenas, both illness- and non–illness-related. In this way, stigma cuts across
dimensions of experience: employment, media, dating, side effects, class, gender,
ethnicity, and religion. This complex intersection speaks to the need to situate and
understand mental illness within the context of lived experience. The experience
of stigma in such specific contexts underscores the complexity of the experiences
of mental illness and recovery. A fuller account of the settings in which stigma
is encountered and strategies for managing it, including hiding the diagnosis and
medications, is given elsewhere (Jenkins and Carpenter-Song n.d.). The problem
of stigma despite improvement calls attention to the significant sacrifices that
mediate experiences of recovery for many participants.
DISCUSSION
In this study of 90 community residents taking second-generation antipsychotic
medications for schizophrenia-related conditions, the levels of symptomatology
were relatively low (in keeping with definitions as set forth by Liberman and
Kopelowicz [2005]), while social and work functioning were relatively high among
many participants. This is the first ethnographic study to systematically investigate
a large community sample of persons taking second-generation antipsychotics,
utilizing narrative and observational data to examine subjective experience.
In light of the finding that only a minority (24.7 percent) report having a sudden
recovery that could qualify as an “awakening,” it appears that hopeful hypotheses
that the atypical antipsychotics might lead to relatively dramatic, substantial, and
sustained recovery for most may not be empirically verifiable (Duckworth 1998;
Duckworth et al. 1997; Stahl 1997). For those who did report such an experience,
the finding of a subtype of awakening (“social” vs. “phenomenological”) as gen-
dered (albeit an infrequent occurrence) likely reflects cultural expectations that
social engagement is an orientation of more concern to women (with or without
schizophrenia alike). The observation that the awakenings phenomenon noted in
the literature (Duckworth 1998; Duckworth et al. 1997; Stahl 1997) was not widely
observed in the SEACORA project provides a cautionary note to avoid sensation-
alizing the nature of improvement as occurred for Sacks’s (1990) Parkinson’s
patients.
Rather, analysis of the narrative data reveals that in this sample, participants’
experience of improvement was observable as a gradual and incremental yet
definitively discernible subjective process. This process does not typically proceed
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in linear fashion but rather occurs in the context of a back-and-forth movement of
slow yet steady improvement (Deegan 1988; Jenkins et al. 2005).
The striking finding that the majority of a sample of previously severely ill
persons felt that their lives and illnesses had improved provides strong evidence to
reject earlier clinical characterizations of schizophrenia as invariably chronic and
degenerative (Kraepelin 1919). The common expectation for improvement in this
study is likely due in part to the self-perceived efficacy of the atypical medications,
on the one hand, and to distinctly American cultural and ethnopsychological
orientations that produce narratives of optimism and progress through individual
effort, on the other (Chang 2001; Shweder and Bourne 1984).
In this study, our finding of incremental improvement and recovery was subjec-
tively considered to be due primarily to the efficacy of the atypical antipsychotic
medications (77.4 percent). This was true despite the concomitant finding of an
exceptionally high rate (90.8 percent) of one or (typically) more substantial side
effects associated with these medications (such as weight gain, drooling, and fa-
tigue). While there were no significant differences by gender or ethnicity in the
extent to which persons considered that they had improved through atypical med-
ications, it is noteworthy that African Americans tended to be somewhat more
likely to report subjective improvement relative to Euro-Americans (76.6 vs. 94.1
percent). While our African American subsample is small (N = 20), the foregoing
finding may serve to underscore the observation that, when available, medications
considered useful may be expected to be subjectively appreciated across a variety
of ethnic and cultural groups alike.
The finding for improvement in association with personal power and control
was split relatively evenly insofar as 51.1 percent affirmed that they had per-
sonal power and control in relation to the illness whereas 48.9 percent did not.
Preliminary review of these distinctively different views indicates various cultural
logics, involving a complicated and uneasily separated triad of person/illness/meds
(Fig. 1). As a matter of personal experience, it is at times difficult to detect where
“I/me,” the meds, and the illness can be differentiated. Different types of patterns
were observed, however, in relation to how these three semantic fields tend to
“go together:”6 e.g., the subjective sense that one has personal power and control
apart from or because of the medication, that one has no personal power or control
because of the power of the medication or illness (or both), and that one’s expe-
rience of stigma as demoralizing affects recovery adversely in contrast to those
who actively reject stigma as part of their life and illness process (Fig. 2).
We are convinced that an absence of agency in terms of the illness is problematic
insofar as such a stance may dissuade one from engaging psychocultural strate-
gies for improvement (Deegan 1988), causing one to resign oneself to the prospect
of having a “broken brain” about which one can do nothing. Broadly speaking
with respect to a middle-class North American ethnopsychological orientation,
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Figure 1. Person–illness–medications experience.
we might expect a certain resonance for personal “power and control,” yet this
may be less true in other societies. Nevertheless, personal agency is highly prob-
lematic even in the American case owing to psychiatric discourse on biochemical
imbalances or deficits about which one can do little besides take medication.
Cultural Trouble with Biochemical Accounts of Mental Disorder
Biochemical discourses engage cultural dimensions of personal responsibility
and agency problematically. On the one hand, a biochemical etiology removes
 
Figure 2. Relationship among factors perceived by patients as being critical to
improvement.
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responsibility for the production of mental illness from individuals and their fami-
lies. Linking mental disorders to imbalances and deficiencies of neurotransmitters
ostensibly places them beyond the scope of families and, indeed, beyond culture.
Conceptualizing schizophrenia as a biochemical imbalance—a disorder of the
brain—places it in a “culture-free zone,” free from blame.
Yet although biochemical and brain-based discourses are intended to do the
undeniably good work of freeing families from blame and individuals from char-
acter flaws, the insidious pervasiveness of the twin problems of “deficient brains”
and the invariably substantial stigma attached to such deficits underscores the
therapeutic limitations of such approaches. Indeed, the intersection of biochem-
istry, mental illness, and responsibility requires further elucidation. As we probe
deeper, it becomes clear that a biological etiology has the secondary consequence
of removing personal agency from the experience of mental illness. This conflicts
with discourses of recovery that emphasize personal control and accountability
to self and to others as significant components of the improvement process. In-
stead, the emphasis on biochemistry might be seen to limit the scope of recovery
to medication and treatment adherence, to the exclusion of other psychocultural
realms.
Recognizing that the subjective experience of recovery is not limited in scope to
the illness itself or to medication compliance creates a space for agency in recovery
from schizophrenia. Individuals participate in the work of recovery, engaging as
active participants in the process. The dimension of personal agency also extends
the process of recovery away from the ill individual and into complex relationships
with others. These social relations tend to de-emphasize illness, highlighting the
fact that their problems, successes, sadnesses, and joys are not bounded by the
illness but are, instead, informed by normatively imagined cultural orientations.
Concluding Remarks
The data lead us to conclude that, in this study, subjective reports of improvement
can be accounted for in part by four factors: the subjectively perceived efficacy of
the atypical medications, a clinical culture shared by fellow patients and clinicians
that reinforces this perceived efficacy, a distinctly American ethnopsychological
orientation that produces narratives of optimism and progress through individual
effort, and, relatively speaking, good contextual factors of residing with or near kin
or friends with economic or social resources to connect patients with psychiatric
care within the community that is sustained. In addition, the fact that the persons
in this study (by virtue of research inclusion criteria designed to focus on medica-
tion experience not complicated by active drug/alcohol abuse) were not currently
burdened also with problems of substance abuse (although several had been in
the past) or homelessness (although several had been in the past) undoubtedly
406 J. H. JENKINS AND E. CARPENTER-SONG
contributes to what can comparatively be considered a better outcome. Thus the
factors key to recovery as identified for this mixed sample of low- to upper-income
participants may only come into play given the presence of these structural features
that can support basic needs and health care that clearly the majority of mentally ill
persons do not generally have (i.e., those who are homeless, incarcerated, without
health care, or entirely disenfranchised from friends and family). In this respect,
the study is socioculturally specific to a group of persons who are relatively sta-
ble in the foregoing respects and is not broadly generalizable to all persons with
mental illness in the absence of such relatively stabilizing features. However, the
SEACORA participants do share a particular kind of social suffering with their
(relatively) more disenfranchised mentally ill counterparts insofar as the struc-
tural poverty associated with being a mental “patient” or “consumer” in this case
invariably involves the necessity of living on an extremely limited governmental
allotment (SSI, Medicaid), the inability to afford a vehicle for transportation, and
an array of other economically based logistical sustenances that others—albeit not
among the very poor or low-income populations—take for granted.
To conclude, in this article, processes of recovery are complex, and often take
on a sense of improvement at one turn and reversals at another, making for a
considerably less than linear process. These incremental processes of improvement
have been examined in relation to medication, personal power and control, and
social stigma for the role they play in the subjective sense of recovery. The
relative roles of these three domains were examined as (1) subjects’ tenacious
convictions that taking medications plays a critical role in managing symptoms
and avoiding hospitalization, (2) active personal engagement in struggling against
the effects of illness, and (3) perceptions of social stigma that attaches to their
conditions despite their having improved substantially (compared to prior illness
states).
We concur with other recovery studies on the importance of several key elements
of the recovery process. First, in relation to our overarching finding regarding the
gradual, incremental, and nonlinear process of recovery, our results are consistent
with Hopper’s (2002) characterization of recovery as complex and “messy.” Our
research project is, to our knowledge, the first to examine empirically the psy-
chiatric and popular notion of “awakenings” from the perspective of persons who
might (or, more likely, might not) experience them. In line with the observation
that recovery from serious mental illness may indeed be messy, we find specifi-
cally that recovery often entails deep ambivalence and substantial sacrifice in the
negotiation of impossible “catch-22” dilemmas. In particular, we have considered
how “social medication effects” and psychiatric stigma create conditions in which
participants must endure the “violences of everyday life” (Kleinman 2000) as they
contend daily with embarrassment and discrimination in their struggle to get better
in the wake of serious mental illness.
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Second, this study affirms previous studies that foreground the importance of
self processes for recovery (Davidson and Strauss 1992). However, in this study we
specify multiplex ways in which individuals locate and situate the self in relation
to illness and recovery, ranging from a sense of returning to an “old self,” to a strict
division between the “ill self” and the “well self,” to the attempt to accommodate
the illness as an aspect of the recovering self. In addition, our analysis reveals the
complexity and ambiguity of agency in the recovery process. In particular, we have
considered how biochemical discourses, which are common explanatory models
for schizophrenia among study participants, complicate rather than resolve issues
of personal power, control, and responsibility.
Third, in keeping with other studies (Davidson 2003; Salokangas 1997) we
note the importance of social support for recovery processes. We observed social
support as a reciprocal process. In addition, our approach to social support calls
attention to recovery as a process that crucially implicates others beyond the
mentally ill individual. In this regard, our study participants likewise articulate
the observation common across the recovery literature that schizophrenia-related
illnesses and recovery need to be situated in relation to multiple stakeholders
(Meddings and Perkins 2002; Stein and Wemmerus 2001). As a shared social
phenomenon we problematize notions of “social support” by illustrating it as
something both received and given, both potentially positive and negative.
Fourth, the SEACORA study corroborates the critical salience of small, con-
crete details of everyday life to include social inclusion for recovery (see also
Davidson 2003). Furthermore, in our study we observed joie de vivre, in con-
trast to broader cultural metanarratives of overnight success. Relatedly, we have
considered how processes of recovery, as subjectively experienced by the study
participants, diverge from traditional anthropological discourses regarding totaliz-
ing ritual conversion (Turner 1967) and, instead, suggest an incremental, additive
transformative process.
In sum, it is clear that improvement and recovery from persistent and severe
mental disorders occur in the complex context of interlocking personal, cultural,
social, and pharmacological effects. Recognizing that the subjective experience of
recovery is not limited in scope to the illness itself or to the problem of medication
“compliance” creates a space for agency in recovery from schizophrenia. Individ-
uals can and do participate in the work of recovery, engaging as active participants
in the process. The dimension of personal agency also extends the process of
recovery away from the ill individual and into complex relationships with others.
Consequently, a significant aspect of recovery is success in diminishing the sway
of illness by force of the momentum and rhythm of lives not constituted entirely
in terms of illness.
The complexity and paradoxical nature of these relations as a matter of subjectiv-
ity suggests the continuing need to specify them more fully through ethnographic
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methods. The goal is to generate new modes of conceptualizing recovery from
schizophrenia in subjectively identified needs and desires of persons struggling to
live ordinary lives after having passed through the portals of tremendous suffering
(Jenkins and Barrett 2004).
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NOTES
1. “Many who treat schizophrenia believe clozapine is the most important medication to
come along in 30 years. The press is so excited, it keeps using ‘Awakenings’ in headlines,
conjuring images of film star Robert De Niro taking a new medicine suddenly going from
comatose to superstar” (New York Times, September 9, 1992: 41).
2. The invoking of patently religious language and symbols in narratives on illness,
suffering, recovery, and medication is a critical topic subject to separate analysis in a
forthcoming publication on magic/science/religion in psychiatric discourse.
3. The salience of the cultural theme of control is by no means unique to Euro- and
African Americans such as those included in this study. While “control” varies in cul-
tural meaning across social settings, it emerges as prominent among many persons, their
kin, and their community when examining the ethnographic materials available on this
issue.
4. Such control by virtue of taking medications was considered by some to be prefer-
ably transacted in the context of a good relationship with one’s doctor. For many, how-
ever, the primary narrative place of the medication in the absence of specific mention
of patient–provider relationships was likewise noteworthy, highlighting the extent to
which psychotherapeutic relations in medication management among this sample are ei-
ther unavailable or underutilized (as is generally true in North America at this historical
moment).
5. The metaphysical dimensions of desire for cure in the face of serious illness are
critical yet beyond the scope of this article. I thank Don Tuzin for noting that this should
be taken into account.
6. See Good’s (1977) classic formulation of semantic fields of meaning and how these
may symbolically tend to “go together” culturally.
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